115.49
price up icon0.50%   0.58
after-market After Hours: 115.49
loading
Revvity Inc stock is traded at $115.49, with a volume of 580.06K. It is up +0.50% in the last 24 hours and down -6.22% over the past month. Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$114.91
Open:
$115.26
24h Volume:
580.06K
Relative Volume:
0.68
Market Cap:
$14.06B
Revenue:
$2.72B
Net Income/Loss:
$254.30M
P/E Ratio:
55.89
EPS:
2.0665
Net Cash Flow:
$564.37M
1W Performance:
+3.36%
1M Performance:
-6.22%
6M Performance:
-4.75%
1Y Performance:
+10.58%
1-Day Range:
Value
$114.27
$115.89
1-Week Range:
Value
$110.95
$116.86
52-Week Range:
Value
$97.31
$129.50

Revvity Inc Stock (RVTY) Company Profile

Name
Name
Revvity Inc
Name
Phone
781-663-6900
Name
Address
77 4TH AVENUE, WALTHAM
Name
Employee
11,500
Name
Twitter
Name
Next Earnings Date
2025-01-31
Name
Latest SEC Filings
Name
RVTY's Discussions on Twitter

Compare RVTY with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
RVTY
Revvity Inc
115.49 14.06B 2.72B 254.30M 564.37M 2.0665
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
539.55 203.55B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
210.41 150.38B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
134.18 38.28B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
459.86 37.40B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
190.97 33.63B 15.41B 1.37B 2.11B 7.50

Revvity Inc Stock (RVTY) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-10-25 Downgrade Bernstein Outperform → Mkt Perform
Dec-13-24 Upgrade BofA Securities Neutral → Buy
Oct-15-24 Upgrade Barclays Equal Weight → Overweight
Aug-28-24 Initiated Wells Fargo Equal Weight
Jul-08-24 Initiated Leerink Partners Outperform
Jun-03-24 Resumed Jefferies Hold
Jan-16-24 Downgrade UBS Buy → Neutral
Jan-04-24 Upgrade Evercore ISI In-line → Outperform
Dec-19-23 Initiated Wells Fargo Equal Weight
Dec-13-23 Initiated Wolfe Research Peer Perform
Sep-28-23 Initiated Bernstein Outperform
Jul-19-23 Initiated Raymond James Outperform
May-23-23 Resumed Goldman Buy
View All

Revvity Inc Stock (RVTY) Latest News

pulisher
Feb 24, 2025

Revvity: Acquisitions In High-Growth Sectors, Excellent Debt Levels Create Notable Growth Potential - Seeking Alpha

Feb 24, 2025
pulisher
Feb 21, 2025

Are Wall Street Analysts Bullish on Revvity Stock? - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

Revvity ignites scientific breakthroughs at SLAS2025 - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

Are Wall Street Analysts Bullish On Revvity Stock? - Barchart

Feb 21, 2025
pulisher
Feb 20, 2025

Massachusetts Court Grants Permanent Injunction To Revvity Against Cloud Software Over Spotfire - Nasdaq

Feb 20, 2025
pulisher
Feb 20, 2025

Revvity Wins Permanent Injunction Enforcing Agreements With Cloud Software Group - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Revvity Wins Permanent Injunction Against Cloud Software Group -February 20, 2025 at 01:06 pm EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Court Ruling Locks In Revvity's Exclusive Control of Critical Spotfire PlatformWhat This Means for Research Markets - StockTitan

Feb 20, 2025
pulisher
Feb 20, 2025

Can't Miss: Revvity's Leadership Team Takes Center Stage at 4 Elite Investor Conferences - StockTitan

Feb 20, 2025
pulisher
Feb 19, 2025

How To Trade (RVTY) - Stock Traders Daily

Feb 19, 2025
pulisher
Feb 18, 2025

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years” - Insider Monkey

Feb 18, 2025
pulisher
Feb 16, 2025

Revvity files complaint against Cloud Software Group - MSN

Feb 16, 2025
pulisher
Feb 15, 2025

Sumitomo Mitsui Trust Group Inc. Purchases 6,814 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

abrdn plc Decreases Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Mirae Asset Global Investments Co. Ltd. Grows Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

Feb 13, 2025
pulisher
Feb 12, 2025

Revvity, Inc. (NYSE:RVTY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 12, 2025
pulisher
Feb 11, 2025

Does Revvity (NYSE:RVTY) Have A Healthy Balance Sheet? - Simply Wall St

Feb 11, 2025
pulisher
Feb 11, 2025

Janney Montgomery Scott LLC Purchases 3,672 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat

Feb 11, 2025
pulisher
Feb 10, 2025

Slocum Gordon & Co LLP Sells 556,579 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat

Feb 10, 2025
pulisher
Feb 09, 2025

Trust Point Inc. Takes $513,000 Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Feb 09, 2025
pulisher
Feb 08, 2025

Revvity (NYSE:RVTY) Is Posting Promising Earnings But The Good News Doesn’t Stop There - Yahoo Finance

Feb 08, 2025
pulisher
Feb 08, 2025

Revvity Gears Up for Q4 Earnings: What's in the Offing? - MSN

Feb 08, 2025
pulisher
Feb 07, 2025

Insider Sell: Michelle Mcmurry-heath Sells Shares of Revvity Inc (RVTY) - GuruFocus.com

Feb 07, 2025
pulisher
Feb 07, 2025

Revvity Director Makes a Bold Move with Stock Sale! - TipRanks

Feb 07, 2025
pulisher
Feb 07, 2025

KeyCorp Forecasts Strong Price Appreciation for Revvity (NYSE:RVTY) Stock - MarketBeat

Feb 07, 2025
pulisher
Feb 06, 2025

Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Feb 06, 2025
pulisher
Feb 06, 2025

Barclays Forecasts Strong Price Appreciation for Revvity (NYSE:RVTY) Stock - MarketBeat

Feb 06, 2025
pulisher
Feb 04, 2025

Revvity (NYSE:RVTY) Updates FY 2025 Earnings Guidance - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Jefferies raises Revvity stock price target to $130, maintains Hold - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Revvity anticipates 3%-5% organic growth in 2025 amid market stabilization - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Revvity’s Strong Recurring Revenue and Growth Prospects Justify Buy Rating - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

Exchange Traded Concepts LLC Sells 3,502 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Revvity, Inc. (NYSE:RVTY) Insider Sells $1,922,494.10 in Stock - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Raymond James Adjusts Price Target on Revvity to $145 From $140 -February 03, 2025 at 11:43 am EST - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

KeyBanc Adjusts Revvity Price Target to $145 From $132 -February 03, 2025 at 11:26 am EST - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

Revvity (NYSE:RVTY) Receives "Outperform" Rating from Raymond James - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Bernstein Adjusts Revvity Price Target to $140 From $130, Maintains Market Perform Rating - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say - MSN

Feb 03, 2025
pulisher
Feb 02, 2025

Revvity, Inc. (NYSE:RVTY) Q4 2024 Earnings Call Transcript - MSN

Feb 02, 2025
pulisher
Feb 02, 2025

Revvity shares leap over 5% as Q4 earnings top estimates - MSN

Feb 02, 2025
pulisher
Feb 01, 2025

Revvity (RVTY) Surpasses Q4 Earnings Estimates - MSN

Feb 01, 2025

Revvity Inc Stock (RVTY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$156.00
price down icon 1.50%
diagnostics_research DGX
$175.41
price up icon 0.78%
diagnostics_research LH
$252.87
price up icon 0.57%
diagnostics_research WAT
$380.83
price up icon 0.41%
diagnostics_research MTD
$1,308.89
price down icon 0.08%
diagnostics_research IQV
$190.97
price down icon 1.94%
Cap:     |  Volume (24h):